House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate if treatment with house dust mite allergen
immunotherapy tablet can reduce the risk of asthma exacerbation in subjects with house dust
mite induced asthma.